2 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Unknown 2 |
Follow Cefoperazone: new trials by email Literature Review of Cefoperazone trials Research Report on Cefoperazone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate Bioequivalence of Burotam (1/1 g/Vial) cefoperazone sodium and sulbactam sodium - Infectious Diseases | Phase 4 | Unknown | Yung Shin Pharm. Ind. Co., Ltd. | 14 | 2022-08-25 | 2023-02-01 |
| Multi-center Clinical Study of Early Antibios of Severe Acute Pancreatitis cefoperazone + metronidazole, oral care by chlorhexidine gluconate, enteral nutrition - Pancreatitis,Acute Necrotizing | Phase 4 | Unknown | Erzhen Chen | 60 | 2012-07-01 | 2013-11-25 |
Communicable Diseases (1) · Pancreatitis, Acute Necrotizing (1)
Erzhen Chen (1) · Yung Shin Pharm. Ind. Co., Ltd. (1)
China (1) · Taiwan (1)
En-Qiang Mao, M.D. & Ph.D. (1) · Er-Zhen Chen, M.D. & Ph.D. (1) · Zhi-Tao Yang, M.D. & Ph.D. (1)